Short-term Outcomes of Concomitant Femoral Derotation Osteotomy and Hip Arthroscopy

Introduction: Workers’ compensation (WC) claims have been associated with poor short-term outcomes after hip arthroscopy. We aim to report mid-term outcomes and return to work (RTW) among patients with WC claims. Methods: Data were prospectively collected and retrospectively reviewed for patients undergoing hip arthroscopy between September 2008 and July 2011. Inclusion criteria were an active WC claim at time of surgery with preoperatively-documented patient-reported outcomes (PROs). Exclusion criteria were a previous hip condition and preoperative Tönnis grade >1. Patient-reported WC cases were pair-matched to non-WC cases based on body mass index (BMI) ± 5, age ± 5 years, gender, preoperative LCEA, labral treatment, and capsular treatment. Results: 52 patients had minimum 5-year outcomes. Mean age was 40.6 (±10.6) years and a mean BMI of 27.5 (±5.3). 9 (16.7%) hips underwent secondary arthroscopies. 5 hips (9.3%) were converted to THA. There were 5 (9.3%) reports of numbness, all of which resolved spontaneously. Work status details were available for 49 patients and 47 patients (95.9%) returned to work. 42 WC hips were matched to 42 control hips. At ⩾5-year follow-up, patient-reported outcomes, visual analogue scale (VAS) and satisfaction were not different between the groups. All magnitudes in improvement were significantly higher in the WC group ( p = < 0.001) except for VAS. No significant differences were found in rates of secondary arthroscopies, conversions to THA, or complications between the groups. Conclusions: WC patients have equal favourable mid-term outcomes as non-WC patients after hip arthroscopy for the treatment of femoroacetabular impingement and labral pathology.

Download Full-text

Resident Involvement in Hip Arthroscopy Procedures Does Not Affect Short-Term Surgical Outcomes

Arthroscopy, Sports Medicine, and Rehabilitation ◽

10.1016/j.asmr.2021.06.005 ◽

2021 ◽

Author(s):

Connor R. Crutchfield ◽

Jack R. Zhong ◽

Nathan J. Lee ◽

David P. Trofa ◽

T. Sean Lynch

Keyword(s):

Surgical Outcomes ◽

Hip Arthroscopy ◽

Short Term ◽

Resident Involvement

Download Full-text

Limited lumbopelvic mobility does not influence short-term outcomes after primary hip arthroscopy: a propensity-matched controlled study

Journal of Hip Preservation Surgery ◽

10.1093/jhps/hnab056 ◽

2021 ◽

Author(s):

Andrew E Jimenez ◽

James D Fox ◽

Kara Miecznikowski ◽

David R Maldonado ◽

Benjamin R Saks ◽

...

Keyword(s):

Hip Arthroscopy ◽

Matched Control ◽

Harris Hip Score ◽

Controlled Study ◽

Control Group ◽

Sacral Slope ◽

Short Term ◽

Matched Control Group ◽

Femoroacetabular Impingement Syndrome ◽

Patient Reported

ABSTRACT There is a paucity of literature investigating the effect of lumbopelvic mobility on patient-reported outcome scores (PROs) after primary hip arthroscopy. The purpose of this study was (i) to report minimum 1-year PROs in patients with limited lumbopelvic mobility (LM) who underwent primary hip arthroscopy for femoroacetabular impingement syndrome (FAIS) and (ii) to compare clinical results with a propensity-matched control group of patients with normal lumbopelvic mobility (NM). Data were reviewed for surgeries performed between November 2019 and March 2020. Patients were considered eligible if they received a primary hip arthroscopy for FAIS in the setting of LM (seated to standing change in sacral slope ≤ 10°). LM patients were propensity-matched to a control group of patients with normal lumbopelvic motion (seated to standing change in sacral slope > 10°) for comparison. A total of 17 LM and 34 propensity-matched NM patients were included in the study. LM patients showed significant improvement in all outcome measures and achieved the minimum clinically important difference (MCID) and patient acceptable symptomatic state (PASS) at high rates for modified Harris Hip Score (MCID: 94% and PASS: 82%) and International Hip Outcome Tool-12 (iHOT-12; MCID: 94% and iHOT-12: 76%). When LM patients were compared to a propensity-matched control group of NM patients, they demonstrated similar postoperative PROs and rates of achieving MCID/PASS. LM patients who undergo primary hip arthroscopy may expect favorable short-term PROs at minimum 1-year follow-up. These results were comparable to a control group of NM patients.

Download Full-text

Does previous hip arthroscopy negatively influence the short term clinical result of total hip replacement?

Archives of Orthopaedic and Trauma Surgery ◽

10.1007/s00402-011-1352-z ◽

2011 ◽

Vol 132 (3) ◽

pp. 299-303 ◽

Cited By ~ 22

Author(s):

Patrick O. Zingg ◽

Alex Schallberger ◽

Hannes A. Rüdiger ◽

Vaughan Poutawera ◽

Claudio Dora

Keyword(s):

Total Hip Replacement ◽

Clinical Result ◽

Hip Arthroscopy ◽

Hip Replacement ◽

Short Term ◽

Total Hip

Download Full-text

Short-term patient-reported outcomes following concomitant hip arthroscopy and the endoscopic modified shelf procedure for the treatment of acetabular dysplasia and intra-articular pathology

Journal of Hip Preservation Surgery ◽

10.1093/jhps/hnab044 ◽

2021 ◽

Author(s):

David R Maldonado ◽

Jade S Owens ◽

Vivian W Ouyang ◽

Benjamin R Saks ◽

Andrew E Jimenez ◽

...

Keyword(s):

Hip Arthroscopy ◽

Patient Reported Outcomes ◽

Acetabular Dysplasia ◽

Short Term ◽

Center Edge ◽

Labral Tears ◽

Patient Reported ◽

Shelf Procedure ◽

Center Edge Angle

Abstract The shelf procedure is a treatment of acetabular dysplasia, with the aim of increasing weight-bearing acetabular coverage. Although several shelf techniques have been described, the endoscopic procedure with concomitant hip arthroscopy is a new, less invasive alternative. Outcomes following this procedure are scarce. The purpose of this study was to report short-term patient-reported outcomes (PROs) following concomitant hip arthroscopy and endoscopic modified shelf procedure in the setting of acetabular dysplasia and labral tears. Patients that met extraordinarily selective surgical indications and underwent the abovementioned surgery between February 2016 and October 2019 and had minimum 1-year follow-up were included. There were five females with a mean age of 40.18 ± 5.05 years and follow-up of 21.55 ± 8.68 months. The lateral center-edge angle increased from 15.80° to 23.20° (P = 0.003), and vertical center-edge angle increased from 16.60° to 23.60° (P < 0.001). The Tönnis angle decreased from 15.40° to 3.74° (P < 0.001). The alpha angle decreased from 58.46° to 40.70° (P < 0.001). PROs demonstrated significant improvement at latest follow-up (modified Harris Hip Score, P = 0.042; Non-Arthritic Hip Score, P < 0.001; Hip Outcome Score–Sports Specific Subscale, P = 0.035; Visual Analog Scale, P < 0.001; International Hip Outcome Tool-12, P = 0.043), and satisfaction was 8.60 ± 0.89. No secondary surgeries were reported. Concomitant hip arthroscopy and endoscopic modified shelf procedure appears to be a safe and effective procedure for patients with acetabular dysplasia and labral tears yielding favorable outcomes and satisfaction at short-term follow-up.

Download Full-text

Rationale for preoperative (versus postoperative) administration of meloxicam for acute pain management and assessment of satisfaction in patients with femoroacetabular impingement who underwent hip arthroscopy

Pain medicine ◽

10.31636/pmjua.v6i1.3 ◽

2021 ◽

Vol 6 (1) ◽

pp. 19-29

Author(s):

Yongqing Li ◽

Guowei Li ◽

Kai Zhang ◽

Menglu Jiang ◽

Xu Dai ◽

...

Keyword(s):

Patient Satisfaction ◽

Adverse Events ◽

Femoroacetabular Impingement ◽

Acute Pain ◽

Hip Arthroscopy ◽

Satisfaction Score ◽

Short Term ◽

Patient Satisfaction Score ◽

Vas Score ◽

Postoperative Administration

Objective: This study is aimed to compare the analgesic effect and safety of preoperative (versus postoperative) meloxicam administration in femoroacetabular impingement (FAI) patients who underwent hip arthroscopy (HA). Methods: Totally, 136 FAI patients who scheduled for HA were recruited, then they were randomly assigned to preoperative administration (PREA) group (orally meloxicam 7.5 mg in 12h, 24h before operation, then orally 7.5 mg/d from 12h to Day 7 after operation; N=68) or postoperative administration (POSA) group (orally meloxicam 7.5 mg/d from 12h to Day 7 after operation; N=68) in 1:1 ratio. Furthermore, pain visual analog scale (VAS) score, patient satisfaction score, Harris hip score (HHS) and adverse events were assessed. Besides, the accumulated pethidine consumption for rescuing analgesia was calculated. Results: Acute pain VAS score at rest (Day1 – Day2) and pain VAS score at motion (Day1 – Day3) were decreased, meanwhile short-term patient satisfaction score (Day1–Day3) was increased in PREA group compared with POSA group; however, these scores in long-term period were of no difference between PREA group and POSA group (Day3–Month3). Furthermore, accumulated pethidine consumption on Day3 and Day7 were attenuated in PREA group compared with POSA group. Additionally, HHS at any assessed time points (Day7–Month3) did not differ between two groups. Besides, no difference in the incidence of adverse events was found between two groups. Conclusions: Preoperative meloxicam administration displays superior efficacy in short-term pain control, patient satisfaction improvement and attenuated consumption of rescue analgesia over postoperative meloxicam administration in FAI patients who underwent HA.

Download Full-text